Dr Richard Manning joins healthcare practice of Bates White
Published: 13 Feb 2012
US economic consulting firm Bates White has appointed Richard Manning, PhD, as partner in its Washington DC and California-based healthcare practice.
Dr Manning has an extensive background providing analysis and thought leadership in public policy and economics for the pharma, biotech and healthcare industries.
Prior to joining Bates White, Dr Manning was executive director of global public policy at Merck & Co, where he oversaw public policy analysis and strategy in worldwide markets. Previously, he was director in the advisory strategy group at PricewaterhouseCoopers (PwC) and specialised in strategic partnerships, deal activity and empirical economic analysis for several pharmaceutical clients.
Dr Manning was also senior director of economic and policy research in the corporate affairs division of Pfizer. During his 12 years with the company, his team provided economic analysis for strategic decision-making on public policy issues. His department also maintained Pfizer’s link to outside academic economists to foster research on key public policy issues.
Eric Gaier, chair of the Bates White Healthcare Practice, commented: "Richard Manning is the perfect addition to our healthcare practice. His notable public policy experience will strengthen a growing area of focus for us. Richard broadens and deepens our team of experts and enhances the value we bring to pharmaceutical and healthcare clients. It's a pleasure to welcome him to our firm."
Published: 13 Feb 2012
Comments are moderated and will not appear until approved by a member of the Communique team.